News

Engineer, Garret Hinson

UI Pharmaceuticals Partners with Protostudios

Thursday, August 25, 2022
The University of Iowa Pharmaceuticals
The engineering and facilities team at UI Pharmaceuticals, the College of Pharmacy’s FDA-registered drug development and manufacturing organization, has been working on innovative ideas and solutions to overcome process and mechanical challenges with the College’s unique pharmaceutical fill-line equipment.

University of Iowa Pharmaceutical client update: Alume Biosciences, Inc, a leader in the field of nerve-targeted diagnostics and therapeutics, today announced that the first patient has been dosed in a Phase 3 pivotal study of ALM-488 (NCT05377554)

Thursday, August 25, 2022
The University of Iowa Pharmaceuticals

UI Pharmaceutical client, Actuate Therapeutics, Announces International Randomized Clinical Trial After Successful Completion of Single Arm Phase 2 Study in Pancreatic Cancer

Friday, November 5, 2021
The University of Iowa Pharmaceuticals

UI Pharmaceutical Client, Actuate Therapeutics Receives Fast Track FDA Designation for 9-ING-41

Tuesday, August 17, 2021

UI Pharmaceuticals Client, G1 Therapeutics Receives FDA Approval for COSELA™ (Trilaciclib)

Saturday, April 17, 2021

UI Pharmaceuticals Chosen as Vendor for NIAID: Formulation, Development, and Manufacture of Clinical Dosage Forms for HIV Therapeutics

Thursday, December 17, 2020

UI Pharmaceuticals Awarded NIH-NCATS Grant for Dosage Form Development and Manufacturing of investigational drug PTH-IA clinical supplies.

Thursday, December 17, 2020

AAPS 2020 PharmSci 360 Meeting

Sunday, October 25, 2020

UI Pharmaceuticals is growing!

Saturday, October 17, 2020

BioProcess International-Boston 2020

Monday, September 21, 2020
RSS feed